Delfi Diagnostics is a company dedicated to saving lives through early cancer detection using their innovative fragmentomics technology. Delfi has pioneered breakthroughs in machine learning and fragmentomics by analyzing cell-free DNA fragments from simple liquid biopsy blood samples to support early-stage cancer detection. Their scalable approach allows them to quickly scan millions of data points to identify previously unrecognized cancer-associated DNA fragments. Delfi Diagnostics collaborates with leading cancer biology, bioinformatics, and machine learning experts to advance their technology. The company has initiated a large-scale clinical trial, CASCADE-LUNG, to validate the effectiveness of its approach.
11 - 50 employees
Founded 2018
𧬠Biotechnology
βοΈ Healthcare Insurance
π Pharmaceuticals
π° $225M Series B on 2022-07
March 20
Lead medical affairs function at DELFI Diagnostics to enhance screening initiatives globally.
π California β Remote
π¦ Maryland β Remote
π΅ $330k - $387k / year
π° $225M Series B on 2022-07
β° Full Time
π΄ Lead
π Vice President
π¦ H1B Visa Sponsor
March 15
Drive clinical management and planning for cancer detection studies at DELFI Diagnostics. Lead cross-functional teams and ensure compliance for studies.
πΊπΈ United States β Remote
π΅ $190k - $210k / year
π° $225M Series B on 2022-07
β° Full Time
π΄ Lead
π§ͺ Clinical Research
π¦ H1B Visa Sponsor
February 8
Drive sales growth as a Clinical Account Representative for DELFIβs diagnostic products in Texas.
π€ Texas β Remote
π΅ $120k - $155k / year
π° $225M Series B on 2022-07
β° Full Time
π‘ Mid-level
π Senior
π§βπΌ Account Executive
π¦ H1B Visa Sponsor
Remote Jobs at Delfi Diagnostics